Scott W. Horsley

Papers

2

Total Citations

346

H-Index

2

About

Scott W. Horsley is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for patients with bladder cancer, particularly through the comparison of robot-assisted and open surgical techniques. His most impactful work, a landmark 2022 study in the *Journal of the American Medical Association* (320 citations), demonstrated that robot-assisted radical cystectomy with intracorporeal urinary diversion does not significantly improve 90-day morbidity or mortality compared to open surgery, challenging prevailing assumptions about the benefits of minimally invasive approaches. This pivotal finding has reshaped clinical decision-making and sparked ongoing debate in the field. Dr. Horsley further advanced the conversation with a 2023 cost-effectiveness analysis (26 citations), revealing that robot-assisted surgery offers limited value to payers relative to its higher costs. His contributions provide critical evidence for balancing innovation with economic and patient-centered outcomes, making him a key voice in evidence-based urologic surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
346
Total Citations
173
Avg Citations/Paper
🏆 Most Cited Paper
Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer
320 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 70

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago